Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity

Journal of Immunological Methods

Volumn 384, Issue 1-2, 2012, Pages 51-61

  Kramski, M ^a   Schorcht, A ^a   Johnston, A P R ^a   Lichtfuss, G F ^b,c   Jegaskanda, S ^a   De Rose, R ^a   Stratov, I ^a   Kelleher, A D ^d   French, M A ^e   Center, R J ^a   Jaworowski, A ^b,c   Kent, S J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BURNET INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antibody dependent cellular cytotoxicity; HIV; Monocytes; NK cells

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; IMMUNOGLOBULIN G;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL POPULATION; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MICROSCOPY; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD14; ANTIGENS, CD3; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; FLOW CYTOMETRY; FLUORESCEINS; FLUORESCENT DYES; HIV; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, FLUORESCENCE; MONOCYTES; ORGANIC CHEMICALS; PHAGOCYTOSIS; SINGLE-CELL ANALYSIS; SUCCINIMIDES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84865609591     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.07.006     Document Type: Article

References (43)

1. Ackerman M.E., Moldt B., Wyatt R.T., Dugast A.S., McAndrew E., Tsoukas S., Jost S., Berger C.T., Sciaranghella G., Liu Q., Irvine D.J., Burton D.R., Alter G. A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. J. Immunol. Methods 2011, 366:8.
2. Ahmad R., Sindhu S.T., Toma E., Morisset R., Vincelette J., Menezes J., Ahmad A. Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection. J. Clin. Immunol. 2001, 21:227.
3. Alter G., Altfeld M. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J. Intern. Med. 2009, 265:29.
4. Barker E., Reisfeld R.A. A mechanism for neutrophil-mediated lysis of human neuroblastoma cells. Cancer Res. 1993, 53:362.
5. Battle-Miller K., Eby C.A., Landay A.L., Cohen M.H., Sha B.E., Baum L.L. Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1-infected women. J. Infect. Dis. 2002, 185:439.
6. Baum L.L., Cassutt K.J., Knigge K., Khattri R., Margolick J., Rinaldo C., Kleeberger C.A., Nishanian P., Henrard D.R., Phair J. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J. Immunol. 1996, 157:2168.
7. Berger C.T., Alter G. Natural killer cells in spontaneous control of HIV infection. Curr. Opin. HIV AIDS 2011, 6:208.
8. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisiddhi T., Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 1990, 172:1633.
9. Bouharoun-Tayoun H., Oeuvray C., Lunel F., Druilhe P. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 1995, 182:409.
10. Center R.J., Wheatley A.K., Campbell S.M., Gaeguta A.J., Peut V., Alcantara S., Siebentritt C., Kent S.J., Purcell D.F. Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens. Vaccine 2009, 27:6605.
11. Chung A.W., Rollman E., Center R.J., Kent S.J., Stratov I. Rapid degranulation of NK cells following activation by HIV-specific antibodies. J. Immunol. 2009, 182:1202.
12. Chung A.W., Navis M., Isitman G., Wren L., Silvers J., Amin J., Kent S.J., Stratov I. Activation of NK cells by ADCC antibodies and HIV disease progression. J. Acquir. Immune Defic. Syndr. 2011, 58:127.
13. Cox J.H. HIV-1-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC). Methods Mol. Med. 1999, 17:373.
14. Cox J.H., Garner R.P., Redfield R.R., Aronson N.E., Davis C., Ruiz N., Birx D.L. Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine. AIDS Res. Hum. Retroviruses 1999, 15:847.
15. Dugast A.S., Tonelli A., Berger C.T., Ackerman M.E., Sciaranghella G., Liu Q., Sips M., Toth I., Piechocka-Trocha A., Ghebremichael M., Alter G. Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals. Virology 2011, 415(2):160-167. (Jul 5).
16. Florese R.H., Demberg T., Xiao P., Kuller L., Larsen K., Summers L.E., Venzon D., Cafaro A., Ensoli B., Robert-Guroff M. Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. J. Immunol. 2009, 182:3718.
17. Gómez-Román V.R., Patterson L.J., Venzon D., Liewehr D., Aldrich K., Florese R., Robert-Guroff M. Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J. Immunol. 2005, 174:2185.
18. Gómez-Román V.R., Florese R.H., Patterson L.J., Peng B., Venzon D., Aldrich K., Robert-Guroff M. A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J. Immunol. Methods 2006, 308:53.
19. Haynes B.F., Gilbert P.B., McElrath M.J., Zolla-Pazner S., Tomaras G.D., Alam S.M., Evans D.T., Montefiori D.C., Karnasuta C., Sutthent R., Liao H.X., DeVico A.L., Lewis G.K., Williams C., Pinter A., Fong Y., Janes H., DeCamp A., Huang Y., Rao M., Billings E., Karasavvas N., Robb M.L., Ngauy V., de Souza M.S., Paris R., Ferrari G., Bailer R.T., Soderberg K.A., Andrews C., Berman P.W., Frahm N., De Rosa S.C., Alpert M.D., Yates N.L., Shen X., Koup R.A., Pitisuttithum P., Kaewkungwal J., Nitayaphan S., Rerks-Ngarm S., Michael N.L., Kim J.H. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 2012, 366:1275.
20. Hessell A.J., Hangartner L., Hunter M., Havenith C.E., Beurskens F.J., Bakker J.M., Lanigan C.M., Landucci G., Forthal D.N., Parren P.W., Marx P.A., Burton D.R. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007, 449:101.
21. Hezareh M., Hessell A.J., Jensen R.C., van de Winkel J.G., Parren P.W. Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1. J. Virol. 2001, 75:12161.
22. Hidajat R., Xiao P., Zhou Q., Venzon D., Summers L.E., Kalyanaraman V.S., Montefiori D.C., Robert-Guroff M. Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques. J. Virol. 2009, 83:791.
23. Horner H., Frank C., Dechant C., Repp R., Glennie M., Herrmann M., Stockmeyer B. Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity. J. Immunol. 2007, 179:337.
24. Huber M., Trkola A. Humoral immunity to HIV-1: neutralization and beyond. J. Intern. Med. 2007, 262:5.
25. Jafarshad A., Dziegiel M.H., Lundquist R., Nielsen L.K., Singh S., Druilhe P.L. A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. J. Immunol. 2007, 178:3099.
26. Johansson S.E., Rollman E., Chung A.W., Center R.J., Hejdeman B., Stratov I., Hinkula J., Wahren B., Kärre K., Kent S.J., Berg L. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients. Viral Immunol. 2011, 24:359.
27. Khusmith S., Druilhe P. Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum. Infect. Immun. 1983, 41:219.
28. Lambotte O., Ferrari G., Moog C., Yates N.L., Liao H.X., Parks R.J., Hicks C., Owzar K., Tomaras G.D., Montefiori D.C., Haynes B.F., Delfraissy J.F. Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 2009, 23:897.
29. Lunel F., Druilhe P. Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect. Immun. 1989, 57:2043.
30. McAndrew E.G., Dugast A.S., Licht A.F., Eusebio J.R., Alter G., Ackerman M.E. Determining the phagocytic activity of clinical antibody samples. J. Vis. Exp. 2011, e3588.
31. Nag P., Kim J., Sapiega V., Landay A.L., Bremer J.W., Mestecky J., Reichelderfer P., Kovacs A., Cohn J., Weiser B., Baum L.L. Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J. Infect. Dis. 2004, 190:1970.
32. Patterson L.J., Daltabuit-Test M., Xiao P., Zhao J., Hu W., Wille-Reece U., Brocca-Cofano E., Kalyanaraman V.S., Kalisz I., Whitney S., Lee E.M., Pal R., Montefiori D.C., Dandekar S., Seder R., Roederer M., Wiseman R.W., Hirsch V., Robert-Guroff M. Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge. Virology 2011, 411:87.
33. Pollara J., Hart L., Brewer F., Pickeral J., Packard B.Z., Hoxie J.A., Komoriya A., Ochsenbauer C., Kappes J.C., Roederer M., Huang Y., Weinhold K.J., Tomaras G.D., Haynes B.F., Montefiori D.C., Ferrari G. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Cytometry A 2011, 79:603.
34. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., Premsri N., Namwat C., de Souza M., Adams E., Benenson M., Gurunathan S., Tartaglia J., McNeil J.G., Francis D.P., Stablein D., Birx D.L., Chunsuttiwat S., Khamboonruang C., Thongcharoen P., Robb M.L., Michael N.L., Kunasol P., Kim J.H., Investigators M.-T. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 2009, 361:2209.
35. Shaw G.M., Levy P.C., LoBuglio A.F. Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells. J. Clin. Invest. 1978, 62:1172.
36. Shaw G.M., Levy P.C., LoBuglio A.F. Human monocyte cytotoxicity to tumor cells. I. Antibody-dependent cytotoxicity. J. Immunol. 1978, 121:573.
37. Sheehy M.E., McDermott A.B., Furlan S.N., Klenerman P., Nixon D.F. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J. Immunol. Methods 2001, 249:99.
38. Stratov I., Chung A., Kent S.J. Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects. J. Virol. 2008, 82:5450.
39. Tiemessen C.T., Shalekoff S., Meddows-Taylor S., Schramm D.B., Papathanasopoulos M.A., Gray G.E., Sherman G.G., Coovadia A.H., Kuhn L. Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1. J. Immunol. 2009, 182:5914.
40. Vaine M., Wang S., Liu Q., Arthos J., Montefiori D., Goepfert P., McElrath M.J., Lu S. Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies. PLoS One 2010, 5:e13916.
41. Wu L., Adams M., Carter T., Chen R., Muller G., Stirling D., Schafer P., Bartlett J.B. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells. Clin. Cancer Res. 2008, 14:4650.
42. Xiao P., Zhao J., Patterson L.J., Brocca-Cofano E., Venzon D., Kozlowski P.A., Hidajat R., Demberg T., Robert-Guroff M. Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J. Virol. 2010, 84:7161.
43. Yamada T., Watanabe N., Nakamura T., Iwamoto A. Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface. J. Immunol. 2004, 172:2401.